GlucoTrack, Inc.

NasdaqCM:GCTK Stock Report

Market Cap: US$13.4m

GlucoTrack Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Paul Goode

Chief executive officer

US$483.2k

Total compensation

CEO salary percentage46.6%
CEO tenureno data
CEO ownership0.5%
Management average tenure2yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

GlucoTrack to start R&D program for glucose monitoring system

Oct 10

CEO Compensation Analysis

How has Paul Goode's remuneration changed compared to GlucoTrack's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$12m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$483kUS$225k

-US$8m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$540kUS$201k

-US$4m

Sep 30 2022n/an/a

-US$5m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$29kn/a

-US$4m

Sep 30 2021n/an/a

-US$3m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$1kn/a

-US$3m

Compensation vs Market: Paul's total compensation ($USD483.24K) is about average for companies of similar size in the US market ($USD677.23K).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.

CEO

Paul Goode (56 yo)

no data

Tenure

US$483,243

Compensation

Mr. Paul V. Goode, Ph D., serves as Chief Executive Officer and President at GlucoTrack, Inc and also serves as its Director since September 2024. He served as President and Chief Operating Officer at Gluc...

Leadership Team

NamePositionTenureCompensationOwnership
Paul Goode
CEO, President & Directorno dataUS$483.24k0.46%
$ 61.6k
Mark Tapsak
Vice President of Technology2yrsUS$176.21k0.22%
$ 29.9k
Drinda Benjamin
Vice President of Marketing1.2yrsno data0.014%
$ 1.9k
James Thrower
Vice President of Engineeringno dataUS$264.11k0.029%
$ 3.9k
Avner Gal
Co-Founder23.7yrsUS$187.39kno data
David Malka
Co-Founder23.7yrsUS$199.35kno data
James Cardwell
Chief Financial Officerless than a yearno datano data

2.0yrs

Average Tenure

56yo

Average Age

Experienced Management: GCTK's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paul Goode
CEO, President & Directorno dataUS$483.24k0.46%
$ 61.6k
Avner Gal
Co-Founder7.5yrsUS$187.39kno data
Luis Malave
Independent Chairman3.3yrsUS$70.00k0.41%
$ 55.0k
Irl Hirsch
Member of Scientific & Clinical Advisory Boardno datano datano data
Robert Fischell
Independent Director14.7yrsUS$70.00k0.20%
$ 26.8k
Lutz Heinemann
Member of Scientific & Clinical Advisory Board9.6yrsno datano data
Barry Ginsberg
Member of Scientific & Clinical Advisory Boardno datano datano data
Allen Danzig
Independent Director4.9yrsUS$70.00k0.15%
$ 20.7k
David Klonoff
Chair of Scientific Advisory Board3.4yrsno datano data
Erin Carter
Independent Director1.1yrsUS$23.33k0.50%
$ 66.6k
Michael Heise
Member of Scientific & Clinical Advisory Boardno datano datano data
Jan Bolinder
Member of Scientific & Clinical Advisory Boardno datano datano data

4.2yrs

Average Tenure

67yo

Average Age

Experienced Board: GCTK's board of directors are considered experienced (4.2 years average tenure).